Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yuya Seko · SciRah

Researcher profile · Semantic Scholar

Yuya Seko

Share profile

Yuya Seko — researcher profile on SciRah

h-index: 36
Works: 159
Citations: 5,474

Most-cited papers

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.
Rodney S. Taylor, R. Taylor, S. Bayliss, H. Hagstrom +14 more
2020Gastroenterology915 citations Open access
Semantic Scholar
The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040
Takanori Ito, M. Ishigami, B. Zou, Taku Tanaka +22 more
2021Hepatology International141 citations
Semantic Scholar
Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease
R. Taylor, S. Bayliss, Hannes Hagström, P. Nasr +11 more
2020103 citations
Semantic Scholar
Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study
Satoshi Oeda, Hirokazu Takahashi, Kento Imajo, Yuya Seko +9 more
2019Journal of gastroenterology75 citations
Semantic Scholar
Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma.
N. Iwai, K. Yasui, Akira Tomie, Y. Gen +13 more
2018International Journal of Oncology75 citations Open access
Semantic Scholar
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma
A. Takahashi, M. Moriguchi, Yuya Seko, H. Ishikawa +21 more
2019Anticancer Research67 citations
Semantic Scholar
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice
Kota Yano, Kanji Yamaguchi, Yuya Seko, Shinya Okishio +11 more
2021Laboratory Investigation59 citations Open access
Semantic Scholar
The genetic backgrounds in nonalcoholic fatty liver disease
Yuya Seko, Kanji Yamaguchi, Y. Itoh
2018Clinical Journal of Gastroenterology52 citations Open access
Semantic Scholar
Incidence of liver cancer in young adults according to the Global Burden of Disease database 2019
P. Danpanichkul, Majd B. Aboona, Banthoon Sukphutanan, Siwanart Kongarin +13 more
2024Hepatology40 citations
Semantic Scholar
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
H. Ishiba, Y. Sumida, Yuya Seko, Saiyu Tanaka +21 more
2020Hepatology Communications40 citations Open access
Semantic Scholar
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma
Kazufumi Kobayashi, S. Ogasawara, A. Takahashi, Yuya Seko +35 more
2021Liver Cancer39 citations Open access
Semantic Scholar
Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review
Y. Kamada, Hirokazu Takahashi, M. Shimizu, T. Kawaguchi +7 more
2021Journal of gastroenterology38 citations
Semantic Scholar
Effect of pemafibrate on fatty acid levels and liver enzymes in non‐alcoholic fatty liver disease patients with dyslipidemia: A single‐arm, pilot study
Yuya Seko, Kanji Yamaguchi, A. Umemura, Kota Yano +7 more
2020Hepatology Research38 citations
Semantic Scholar
Diagnostic accuracy of FibroScan‐AST score to identify non‐alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non‐alcoholic fatty liver disease: Comparison between M and XL probes
Satoshi Oeda, Hirokazu Takahashi, Kento Imajo, Yuya Seko +12 more
2020Hepatology Research37 citations
Semantic Scholar
Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
P. Danpanichkul, Vincent L. Chen, N. Chaiyakunapruk, Thanida Auttapracha +17 more
2024Alimentary Pharmacology and Therapeutics34 citations Open access
Semantic Scholar
Role of vitamin E in the treatment of non-alcoholic steatohepatitis.
Y. Sumida, M. Yoneda, Yuya Seko, Hirokazu Takahashi +6 more
2021Free Radical Biology & Medicine32 citations Open access
Semantic Scholar
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Y. Sumida, Masashi Yoneda, Yuya Seko, H. Ishiba +17 more
2020Diagnostics32 citations Open access
Semantic Scholar
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease
Yuya Seko, Y. Sumida, Saiyu Tanaka, Kojiroh Mori +13 more
2018Hepatology Research32 citations Open access
Semantic Scholar
The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study
Yuya Seko, Kanji Yamaguchi, T. Shima, Michihiro Iwaki +11 more
2023Liver international (Print)31 citations
Semantic Scholar
Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non‐alcoholic fatty liver disease
Yuya Seko, Kanji Yamaguchi, N. Tochiki, Kota Yano +10 more
2020Liver international (Print)31 citations
Semantic Scholar
FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
Yuya Seko, Kohtaro Yano, A. Takahashi, Shinya Okishio +11 more
2019International Journal of Molecular Sciences29 citations Open access
Semantic Scholar
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease
Takuma Nakatsuka, R. Tateishi, Masaya Sato, Natsuka Hashizume +22 more
2024Hepatology28 citations Open access
Semantic Scholar
The Burden of Overweight and Obesity-Associated Gastrointestinal Cancers in Low and Lower-Middle-Income Countries: A Global Burden of Disease 2019 Analysis
P. Danpanichkul, Thanida Auttapracha, Banthoon Sukphutanan, Cheng H. Ng +14 more
2024American Journal of Gastroenterology27 citations
Semantic Scholar
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
Seita Kataoka, A. Umemura, Keiichiroh Okuda, Hiroyoshi Taketani +9 more
2021International Journal of Molecular Sciences25 citations Open access
Semantic Scholar
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
K. Kodama, T. Kawaguchi, H. Hyogo, T. Nakajima +20 more
2019Journal of Gastroenterology and Hepatology25 citations
Semantic Scholar
Accuracy of non‐invasive scoring systems for diagnosing non‐alcoholic steatohepatitis‐related fibrosis: Multicenter validation study
Y. Itoh, Yuya Seko, T. Shima, T. Nakajima +12 more
2018Hepatology Research25 citations
Semantic Scholar
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease
Yuya Seko, Kanji Yamaguchi, Naoki Mizuno, Keiichiroh Okuda +16 more
2018Journal of gastroenterology24 citations
Semantic Scholar
A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma and high tumor burden: The LAUNCH study.
Kazufumi Kobayashi, S. Ogasawara, Susumu Maruta, T. Okubo +28 more
2023Clinical Cancer Research23 citations
Semantic Scholar
Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB‐4 index
Yuya Seko, M. Moriguchi, Tasuku Hara, Seita Kataoka +10 more
2019Hepatology Research23 citations
Semantic Scholar
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis‐related fibrosis: Multicenter study
Yuya Seko, Hirokazu Takahashi, H. Toyoda, H. Hayashi +22 more
2022Hepatology Research21 citations Open access
Semantic Scholar
Accuracy of the enhanced liver fibrosis test in patients with type 2 diabetes mellitus and its clinical implications.
T. Arai, Hirokazu Takahashi, Yuya Seko, H. Toyoda +23 more
2023Clinical Gastroenterology and Hepatology20 citations Open access
Semantic Scholar
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
A. Takahashi, M. Moriguchi, Yuya Seko, T. Shima +22 more
2020Cancers20 citations Open access
Semantic Scholar
Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction
Kento Takeuchi, Kanji Yamaguchi, Yusuke Takahashi, Kota Yano +11 more
2024Scientific Reports19 citations Open access
Semantic Scholar
Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
Keiichiroh Okuda, A. Umemura, S. Umemura, Seita Kataoka +11 more
2021Cancers19 citations Open access
Semantic Scholar
Clinical and pathological features of sarcopenia‐related indices in patients with non‐alcoholic fatty liver disease
Yuya Seko, Naoki Mizuno, Shinya Okishio, A. Takahashi +10 more
2019Hepatology Research19 citations
Semantic Scholar
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis
Benjamin Koh, J. Xiao, Cheng H. Ng, Michelle Law +17 more
2024Hepatology17 citations
Semantic Scholar
Medical checkup data analysis method based on LiNGAM and its application to nonalcoholic fatty liver disease
Tsuyoshi Uchida, Koichi Fujiwara, K. Nishioji, M. Kobayashi +5 more
2022Artif. Intell. Medicine17 citations Open access
Semantic Scholar
PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat
Shinya Okishio, Kanji Yamaguchi, H. Ishiba, N. Tochiki +15 more
2020Scientific Reports17 citations Open access
Semantic Scholar
Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease.
Yuya Seko, Kanji Yamaguchi, T. Shima, Michihiro Iwaki +8 more
2024Clinical Gastroenterology and Hepatology15 citations
Semantic Scholar
Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver‐Related Events in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Yuya Seko, Kanji Yamaguchi, T. Shima, Michihiro Iwaki +8 more
2024Liver international (Print)15 citations
Semantic Scholar
Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma
T. Okanoue, Kanji Yamaguchi, T. Shima, Y. Mitsumoto +7 more
2022Hepatology Research15 citations
Semantic Scholar
Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells
A. Takahashi, A. Umemura, Kota Yano, Shinya Okishio +7 more
2021Frontiers in Oncology15 citations Open access
Semantic Scholar
Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease
Yuya Seko, Hua-Peng Lin, V. Wong, T. Okanoue
2024Liver international (Print)14 citations
Semantic Scholar
Potential Therapeutic Targets and Promising Agents for Combating NAFLD
A. Umemura, Seita Kataoka, Keiichiroh Okuda, Yuya Seko +4 more
2022Biomedicines14 citations Open access
Semantic Scholar
The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease
Yuya Seko, Kanji Yamaguchi, N. Tochiki, Kota Yano +7 more
2021Genes13 citations Open access
Semantic Scholar
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease
M. Kawanaka, Yoshihiro Kamada, Hirokazu Takahashi, Michihiro Iwaki +10 more
2024Gastro Hep Advances12 citations Open access
Semantic Scholar
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease
Satoshi Oeda, Yuya Seko, H. Hayashi, T. Arai +22 more
2023Hepatology Research12 citations
Semantic Scholar
Re-administration of nivolumab after immune checkpoint inhibitor-induced cholangitis: the first reported case
Seita Kataoka, M. Moriguchi, Shinya Okishio, A. Takahashi +6 more
2022Clinical Journal of Gastroenterology12 citations
Semantic Scholar
Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress
Keiichiroh Okuda, A. Umemura, Seita Kataoka, Kota Yano +14 more
2021Frontiers in Oncology11 citations Open access
Semantic Scholar
Serum soluble sialic acid‐binding immunoglobulin‐like lectin‐7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non‐alcoholic fatty liver disease
Y. Sakamoto, S. Yoshio, Hiroyoshi Doi, Hironari Kawai +16 more
2019Hepatology Research11 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Y. Itoh×32
Invite
Y. Itoh — researcher profile on SciRah
Kanji Yamaguchi×31
Invite
Kanji Yamaguchi — researcher profile on SciRah
M. Moriguchi×25
Invite
M. Moriguchi — researcher profile on SciRah
T. Okanoue×21
Invite
T. Okanoue — researcher profile on SciRah

×20

Invite

A. Umemura — researcher profile on SciRah

Seita Kataoka×15

Invite

Seita Kataoka — researcher profile on SciRah

Keiichiroh Okuda×15

Invite

Keiichiroh Okuda — researcher profile on SciRah

Invite

T. Shima — researcher profile on SciRah

A. Takahashi×13

Invite

A. Takahashi — researcher profile on SciRah

Shinya Okishio×11

Invite

Shinya Okishio — researcher profile on SciRah

M. Kawanaka×10

Invite

M. Kawanaka — researcher profile on SciRah

Hirokazu Takahashi×9

Invite

Hirokazu Takahashi — researcher profile on SciRah